arrow
K

Karyne Martel

mcgill university
H指数:6
被引数:142

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trends in breast reconstruction for BRCA1/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy

BRCA1/2、PALB2及其他高外显率胚系致病性变异携带者接受风险降低性乳房切除术后的乳房再造趋势

2026-04-280
PRE
ASO Visual Abstract: Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen

ASO视觉摘要:阿typical Hyperplasia和Lobular Carcinoma In Situ患者中内分泌预防的依从性:低剂量他莫昔芬真实世界使用中的良好趋势

2026-03-130
PRE
Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen

阿特ypical Hyperplasia和Lobular Carcinoma In Situ患者中内分泌预防的依从性:低剂量他莫昔芬真实世界应用的良好趋势

2026-02-070
PRE
ASO Visual Abstract: Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing After 60 Years of Age

ASO视觉摘要:60岁后接受基因检测的老年BRCA1/2和PALB2携带者中风险降低性乳房切除术的接受情况

2025-11-100
PRE
Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study

乳腺癌新辅助化疗后保乳手术患者切缘状态对局部复发的影响: 一项多机构回顾性队列研究

2024-07-050
PRE
Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy

BRCA1/2和PALB2-Associated乳腺癌基因检测的时机: 术前结果披露增加了降低风险的乳房切除术的吸收,减少了不必要的放疗暴露

EJSO
IF2.9
2024-06-015
PRE
Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study

多发性同侧乳腺癌新辅助化疗后保乳手术的肿瘤学安全性: 一项多机构回顾性队列研究

EJSO
IF2.9
2024-06-012
OAAI